http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017052355-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe3f2d4f405df889e4d23b14700ba764 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate | 2016-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fb841eb27e373320ebfb099e4f41db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5432d68c75fa8710628df212b29aa5c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e31f36072998684295f217a745456cde |
| publicationDate | 2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017052355-A2 |
| titleOfInvention | Use of peptide drugs for the treatment of osteoporosis and for bone regeneration |
| abstract | The present invention provides osteogenic peptides derived from cementum attachment protein (HACD1/CAP) and another derived from cementum protein 1 (CEMP1), and pharmaceutical compositions of said peptides for the prevention and treatment of osteopenia and osteoporosis. These peptides increased bone mineral density in an osteoporotic model, without side effects in vivo , demonstrating clinical effectiveness in the prevention and treatment of osteopenia and osteoporosis in vivo , as well as in bone repair and/or regeneration. |
| priorityDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 243.